Juliet Tammenoms - Feb 12, 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Role: Director
Signature: /s/ Cristiana Blauth Oliveira as Attorney-in-fact for Juliet Tammenoms Bakker
Stock symbol: RXST
Transactions as of: Feb 12, 2024
Transactions value $: $406,673
Form type: 4
Date filed: 2/15/2024, 04:15 PM
Previous filing: Nov 30, 2023
Next filing: May 21, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXST	Common Stock	Purchase	$202K	+4K	+18.32%	$50.38	25.8K	Feb 12, 2024	Direct	F1
transaction	RXST	Common Stock	Purchase	$205K	+4K	+15.48%	$51.29	29.8K	Feb 14, 2024	Direct
holding	RXST	Common Stock						1.55K	Feb 12, 2024	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction is being reported late due to inadvertent administrative error.
F2	These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

Content

This transaction is being reported late due to inadvertent administrative error.

These securities are held by a trust. The Reporting Person, a member of the Issuer's board of directors, is the Investment Trustee of such trust and may be deemed to share voting, investment and dispositive power with respect to such securities. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.